Sign In
Buy ARDX
$6.18
-0.190 (-2.98%)
At Close: Jun 23, 2026
Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
04:01pm, Thursday, 01'st Aug 2024
IBSRELA generates $35.4 million in net product sales revenue XPHOZAH generates $37.1 million in net product sales revenue Company ends Q2 with approximately $186 million in cash and investments Con
WALTHAM, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class med
Get Your Money Out of These 3 Biotech Stocks Before the End of July
09:00am, Sunday, 28'th Jul 2024
Biotech stocks are known for their high volatility and potential for massive gains. The success in the sector often hinges on progressive and often groundbreaking medical advancements.
Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?
11:08am, Thursday, 25'th Jul 2024
Ardelyx (ARDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ardelyx sues US health department over kidney disease drug
06:47pm, Wednesday, 17'th Jul 2024
Drugmaker Ardelyx said on Wednesday that it has filed a lawsuit against the U.S. Department of Health and Human Services and the Centers for Medicare and Medicaid Services (CMS) over their plan to inc
Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines
05:10pm, Wednesday, 17'th Jul 2024
Lawsuit challenges CMS's statutory overreach in its determination to include oral-only phosphate-lowering therapies in the End-Stage Renal Disease Prospective Payment System
Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook
08:00am, Saturday, 13'th Jul 2024
Ardelyx declined last week after the company said it will not apply for TDAPA with the CMS for Xphozah to be included in the bundle in 2025. Legislative efforts may provide temporary relief for Xphoza
ARDX Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Ardelyx, Inc. for Potential Securities Law Violations
03:12pm, Tuesday, 02'nd Jul 2024
MONSEY, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Ardelyx, Inc. (Nasdaq: ARDX) (“Ardelyx”) has violated the federal securities laws after
To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA
07:00am, Tuesday, 02'nd Jul 2024
Ardelyx continues support for bipartisan legislation that would extend the exclusion of oral-only medications from entering the CMS Prospective Payment System
Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines
08:17am, Friday, 28'th Jun 2024
WALTHAM, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class med
3 Promising Penny Stocks for the Most Astute Investors
07:30am, Monday, 24'th Jun 2024
Even though they are among the riskiest stocks on the market, investing in some penny stocks can mean a lot of profits. In times of economic uncertainty, penny stock investment can be a lifesaver for
3 Stocks Under $10 With the Potential to Make You a Millionaire
06:17am, Sunday, 16'th Jun 2024
Buying stocks that can make you millions is any investor's dream. That is why some investors consider micro-cap or small-cap stocks trading under $10.
Ardelyx, Inc. Reports Employment Inducement Grants
04:02pm, Thursday, 30'th May 2024
WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class med
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
03:30pm, Thursday, 30'th May 2024
Human life expectancy has doubled since the 1900s, mostly attributed to advancements in lifestyle, living standards and medicine. Thanks to biotech companies that produce transformative drugs and trea
Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
08:02am, Wednesday, 22'nd May 2024
WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medi
